The lung microbiome: new research into the pathogenesis and prognosis of lung cancer

New research from the Lung Microbiome Program at New York University Grossman School of Medicine (NY, USA) has demonstrated the role of certain microbiota in activating immune responses in the lungs and contributing to the pathogenesis of lung cancer. The study, published recently in Cancer Discovery, also shows that the presence of certain microbiota in the lungs upon diagnosis is linked to disease stage and survival. The 83 participant  study included investigations with tissue samples and mouse models of lung cancer. Leopoldo Segal, Director of the Lung Microbiome Program at New York University (NY, USA) has previously shown that oral...